Philippe Truffinet
Chilly, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Psychometric validation of PROMIS-Fatigue-MS-8a and MSIS-29v2 questionnaires in relapsing multiple sclerosis participants enrolled in a phase 2 trial of frexalimab.
Journal: Multiple sclerosis and related disorders
Published: July 16, 2025
Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis.
Journal: Neurology and therapy
Published: May 15, 2024
Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 15, 2024
Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
Journal: The New England journal of medicine
Published: February 14, 2024
Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: January 12, 2023
Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide.
Journal: Frontiers in neurology
Published: December 03, 2021
Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial.
Journal: The Lancet. Neurology
Published: February 25, 2021
Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study.
Journal: Multiple sclerosis and related disorders
Published: February 26, 2020
Pregnancy outcomes in patients treated with leflunomide, the parent compound of the multiple sclerosis drug teriflunomide.
Journal: Reproductive toxicology (Elmsford, N.Y.)
Published: October 15, 2019
Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 08, 2019
Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 11, 2019
Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study★★.
Journal: Multiple sclerosis and related disorders
Published: March 04, 2019
Last Updated: 09/26/2026